Back
Vericel Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
61
VCEL
Vericel
Last Price:
52.83
Seasonality Move:
17.21%
Buy
69
HALO
Halozyme Therapeutics
Last Price:
53.92
Seasonality Move:
17.03%
Buy
61
Vericel (VCEL)
is a Buy
Is Vericel a Buy, Sell or Hold?
- The current Vericel [VCEL] share price is $55.47. The Score for VCEL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- VCEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $58.61. The Score for HALO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VCEL Stock Price Chart
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $58.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
VCEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3 | Buy |
| Relative Strength Index (14 RSI): | 75.63 | Buy |
| Chaikin Money Flow: | -173260 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.48 - 50.4) | Buy |
| Bollinger Bands (100): | (42.81 - 50.37) | Buy |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.38 | Buy |
| Relative Strength Index (14 RSI): | 57.76 | Buy |
| Chaikin Money Flow: | -684125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.34 - 58.42) | Buy |
| Bollinger Bands (100): | (52.31 - 60.31) | Buy |
VCEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.17 | Buy |
| 20-day SMA: | 46.46 | Buy |
| 50-day SMA: | 44.8 | Buy |
| 200-day SMA: | 46.72 | Buy |
| 8-day EMA: | 52.18 | Buy |
| 20-day EMA: | 48.25 | Buy |
| 50-day EMA: | 46.26 | Buy |
| 200-day EMA: | 44.83 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.73 | Sell |
| 20-day SMA: | 54.8 | Buy |
| 50-day SMA: | 56.65 | Buy |
| 200-day SMA: | 48.77 | Buy |
| 8-day EMA: | 58.73 | Sell |
| 20-day EMA: | 56.7 | Buy |
| 50-day EMA: | 56.13 | Buy |
| 200-day EMA: | 50.75 | Buy |
Vericel Earnings Growth & VCEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.39 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.66 per share.
Vericel Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||